Correlation Between Travere Therapeutics and PTC Therapeutics
Can any of the company-specific risk be diversified away by investing in both Travere Therapeutics and PTC Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Travere Therapeutics and PTC Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Travere Therapeutics and PTC Therapeutics, you can compare the effects of market volatilities on Travere Therapeutics and PTC Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Travere Therapeutics with a short position of PTC Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Travere Therapeutics and PTC Therapeutics.
Diversification Opportunities for Travere Therapeutics and PTC Therapeutics
0.42 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Travere and PTC is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding Travere Therapeutics and PTC Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PTC Therapeutics and Travere Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Travere Therapeutics are associated (or correlated) with PTC Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PTC Therapeutics has no effect on the direction of Travere Therapeutics i.e., Travere Therapeutics and PTC Therapeutics go up and down completely randomly.
Pair Corralation between Travere Therapeutics and PTC Therapeutics
Given the investment horizon of 90 days Travere Therapeutics is expected to under-perform the PTC Therapeutics. In addition to that, Travere Therapeutics is 1.34 times more volatile than PTC Therapeutics. It trades about -0.21 of its total potential returns per unit of risk. PTC Therapeutics is currently generating about -0.26 per unit of volatility. If you would invest 5,249 in PTC Therapeutics on January 8, 2025 and sell it today you would lose (967.00) from holding PTC Therapeutics or give up 18.42% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Travere Therapeutics vs. PTC Therapeutics
Performance |
| Timeline |
| Travere Therapeutics |
| PTC Therapeutics |
Travere Therapeutics and PTC Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Travere Therapeutics and PTC Therapeutics
The main advantage of trading using opposite Travere Therapeutics and PTC Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Travere Therapeutics position performs unexpectedly, PTC Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PTC Therapeutics will offset losses from the drop in PTC Therapeutics' long position.| Travere Therapeutics vs. Cytokinetics | Travere Therapeutics vs. Ventyx Biosciences | Travere Therapeutics vs. Cogent Biosciences | Travere Therapeutics vs. Nuvalent |
| PTC Therapeutics vs. Krystal Biotech | PTC Therapeutics vs. Sarepta Therapeutics | PTC Therapeutics vs. Iovance Biotherapeutics | PTC Therapeutics vs. Madrigal Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Complementary Tools
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |